Clinical Trials Browser

Neurotoxicity Syndromes × Lorazepam × Clear all

NCT01949662 2026-02-13

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

Phase 2 Active not recruiting

93 enrolled 14 charts

Other hematologic neoplasm

Delirium, Hematologic Neoplasms, Neurotoxicity Syndromes